Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannTrust Holdings Inc CNTTQ

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
CannTrust Holdings Inc is engaged in the business of producing and distributing medical cannabis in Canada. Its facility is located at Vaughan, Ontario in Canada. Its brands include LIIV, ESCAPE, SYNR.G and Peak Leaf.


GREY:CNTTQ - Post by User

CannTrust Holdings Inc
Bullboard Posts
User Avatar Image
(18)
•••
Comment by wizzard89on Sep 26, 2019 6:51pm
88 Views
Post# 30168515

RE:Personally I think they survive.

RE:Personally I think they survive.You missed the part where HC has NOT said they have to DESTROY anything and in FACT are able to finish and package this grow cycle,meaning they will have MILLIONS in product available to be sold the DAY they get a licence back. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities